NEW YORK, March 15 – Oxford Glycosciences of Oxford, UK, has apparently changed its plans for entering the protein microarray market, saying Thursday that their collaboration with Packard Biosciences and Cambridge Antibody Technologies is “just a research project” and that the company has no immediate plans to commercialize the technology. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.